Omeicos Therapeutics – Active
Omeicos is developing novel small molecule drugs for the treatment and prevention of atrial fibrillation using a first-in-class novel metabolite of omega 3 fatty acids.
| Sector: | Therapeutic |
| Country: | Germany |
| Status: | Active |